View in EDS

Synthesizing the latest guideline-based recommendations for the management of female hypogonadism.

Saved in:
Bibliographic Details
Title: Synthesizing the latest guideline-based recommendations for the management of female hypogonadism.
Authors: Barbar B; Hospital de Base, Faculdade de Medicina de São José do Rio Preto, São José do Rio Preto, SP, Brasil., Osman W; National Diabetes and Endocrine Centre, Royal Hospital, Muscat, Oman.; Department of Metabolism, Digestion & Reproduction, Imperial College London, London, UK., Jayasena CN; Section of Investigative Medicine, Hammersmith Hospital, Imperial College London, London, UK., Quinton R; Imperial College London Department of Metabolism, Digestion & Reproduction London UK Department of Metabolism, Digestion Reproduction, Imperial College London, London, UK.; Department of Metabolism, Digestion & Reproduction, Imperial College London, London, UK.
Source: Archives of endocrinology and metabolism [Arch Endocrinol Metab] 2025 Dec 03; Vol. 70 (Spe1), pp. e250395. Date of Electronic Publication: 2025 Dec 03.
Publication Type: Journal Article; Review
Language: English
Journal Info: Publisher: Segmento Farma Editores Country of Publication: Brazil NLM ID: 101652058 Publication Model: Electronic Cited Medium: Internet ISSN: 2359-4292 (Electronic) Linking ISSN: 23593997 NLM ISO Abbreviation: Arch Endocrinol Metab Subsets: MEDLINE
Imprint Name(s): Original Publication: São Paulo, SP : Segmento Farma Editores
MeSH Terms: Hypogonadism*/therapy , Hypogonadism*/etiology , Hypogonadism*/diagnosis , Practice Guidelines as Topic*, Humans ; Female ; Turner Syndrome/therapy ; Primary Ovarian Insufficiency/therapy
Abstract: Over the past year, three new key guidelines have been published in the area of female hypogonadism, one from the Society for Endocrinology covering the full spectrum of causes of female hypogonadism in adult life, which will form the core of this review; another solely covering premature ovarian insufficiency from a consortium comprising the International Menopause Society (IMS), the European Society of Human Reproduction & Embryology (ESHRE) and the American Society for Reproductive Medicine (ASRM) that updates the 2016 ESHRE guidance, and a third covering Turner syndrome across all stages of life from the International Turner Syndrome Consensus Group. In this review, we aim to synthesize the key elements from all of these documents, providing a timely update for clinicians managing affected women.
References: Acta Obstet Gynecol Scand. 2019 May;98(5):559-562. (PMID: 30801655)
Semin Arthritis Rheum. 2011 Dec;41(3):346-52. (PMID: 21868068)
J Clin Endocrinol Metab. 2014 Jun;99(6):E953-61. (PMID: 24517142)
Endocr Rev. 2016 Dec;37(6):636-675. (PMID: 27828722)
Front Endocrinol (Lausanne). 2019 Oct 11;10:685. (PMID: 31681164)
Endocr Rev. 2019 Apr 1;40(2):669-710. (PMID: 30698671)
Ann Clin Biochem. 2016 Jan;53(Pt 1):10-20. (PMID: 25933804)
Lancet. 2024 Jun 15;403(10444):2632-2648. (PMID: 38735295)
Clin Endocrinol (Oxf). 2023 Mar;98(3):454-456. (PMID: 36342078)
Clin Endocrinol (Oxf). 2025 Jan;102(1):75-78. (PMID: 39363561)
Hum Reprod Update. 2014 Jul-Aug;20(4):485-500. (PMID: 24615662)
JAMA Oncol. 2024 Jan 1;10(1):103-108. (PMID: 37917089)
Hum Reprod. 2016 May;31(5):926-37. (PMID: 27008889)
Maturitas. 2024 Jan;179:107871. (PMID: 37925867)
Lancet Public Health. 2019 Nov;4(11):e553-e564. (PMID: 31588031)
Nat Med. 2023 Jul;29(7):1692-1699. (PMID: 37349538)
Nat Med. 2023 Feb;29(2):483-492. (PMID: 36732629)
Proc Natl Acad Sci U S A. 2014 Dec 16;111(50):17953-8. (PMID: 25472840)
Lancet Diabetes Endocrinol. 2021 Apr;9(4):235-246. (PMID: 33647242)
J Clin Endocrinol Metab. 2017 May 1;102(5):1413-1439. (PMID: 28368518)
J Clin Endocrinol Metab. 2011 Dec;96(12):3864-72. (PMID: 21994953)
Case Rep Womens Health. 2020 Nov 12;29:e00270. (PMID: 33294389)
Int J Cancer. 2004 May 1;109(5):721-7. (PMID: 14999781)
EBioMedicine. 2022 Oct;84:104246. (PMID: 36099812)
Wiley Interdiscip Rev Dev Biol. 2012 Jul-Aug;1(4):533-57. (PMID: 22844349)
Adv Pediatr. 2016 Aug;63(1):127-46. (PMID: 27426898)
Oxid Med Cell Longev. 2021 Jun 28;2021:5523516. (PMID: 34257804)
Cureus. 2023 Aug 6;15(8):e43053. (PMID: 37680393)
Clin Endocrinol (Oxf). 2001 Aug;55(2):163-74. (PMID: 11531922)
Hum Reprod Update. 2023 May 2;29(3):327-346. (PMID: 36651193)
Front Endocrinol (Lausanne). 2023 Mar 23;14:1160258. (PMID: 37033245)
Hum Reprod Update. 2022 May 2;28(3):417-434. (PMID: 35199161)
Endocr Rev. 2022 Sep 26;43(5):824-851. (PMID: 34864951)
Am J Med Genet C Semin Med Genet. 2017 Dec;175(4):397-406. (PMID: 29171162)
Life (Basel). 2023 May 18;13(5):. (PMID: 37240854)
Int J Sport Nutr Exerc Metab. 2018 Jul 1;28(4):316-331. (PMID: 29771168)
Clin Endocrinol (Oxf). 2024 Nov;101(5):409-442. (PMID: 39031660)
Int J Mol Sci. 2023 Mar 31;24(7):. (PMID: 37047549)
JAMA. 1998 Aug 19;280(7):605-13. (PMID: 9718051)
Hum Genet. 2021 Jan;140(1):77-111. (PMID: 32200437)
N Engl J Med. 2004 Sep 2;351(10):987-97. (PMID: 15342807)
Endocr Rev. 2013 Jun;34(3):309-38. (PMID: 23460719)
Front Pharmacol. 2022 Apr 12;13:850815. (PMID: 35496275)
J Investig Med. 2009 Dec;57(8):830-6. (PMID: 19574929)
N Engl J Med. 2011 Jan 20;364(3):215-25. (PMID: 21247312)
J Clin Endocrinol Metab. 2016 Sep;101(9):3497-505. (PMID: 27340881)
J Clin Endocrinol Metab. 2021 Mar 8;106(3):e1441-e1452. (PMID: 32870266)
Eur J Endocrinol. 2024 Jun 5;190(6):G53-G151. (PMID: 38748847)
Clin Endocrinol (Oxf). 2025 Jan;102(1):67-74. (PMID: 39279431)
Endocr Connect. 2017 Aug;6(6):404-412. (PMID: 28698240)
Climacteric. 2024 Dec;27(6):510-520. (PMID: 39647506)
Endocrinology. 2011 Jun;152(6):2465-73. (PMID: 21447630)
Hum Reprod Open. 2020 Oct 25;2020(4):hoaa045. (PMID: 33134561)
Ann N Y Acad Sci. 2024 Oct;1540(1):21-46. (PMID: 39287750)
J Pediatr Endocrinol Metab. 2023 Nov 24;37(1):1-7. (PMID: 37997801)
Lancet Oncol. 2016 May;17(5):567-76. (PMID: 27020005)
Front Endocrinol (Lausanne). 2022 Sep 27;13:1008306. (PMID: 36237189)
Climacteric. 2011 Oct;14(5):565-72. (PMID: 21854296)
Nat Rev Endocrinol. 2015 Sep;11(9):547-64. (PMID: 26194704)
J Steroid Biochem Mol Biol. 2008 Mar;109(1-2):11-5. (PMID: 18206365)
Eur J Endocrinol. 2016 Jun;174(6):R239-47. (PMID: 26733480)
Am J Nephrol. 2006;26(2):170-80. (PMID: 16645264)
Front Endocrinol (Lausanne). 2022 Jul 22;13:953180. (PMID: 35937789)
Menopause. 2020 Mar;27(3):361-370. (PMID: 31794498)
Maturitas. 2021 Jun;148:24-32. (PMID: 34024348)
Hum Reprod. 2002 Jun;17(6):1464-7. (PMID: 12042262)
J Clin Endocrinol Metab. 2012 Apr;97(4):E694-9. (PMID: 22319038)
EClinicalMedicine. 2023 Jun 08;60:102033. (PMID: 37396803)
Physiol Rev. 2020 Jul 1;100(3):1149-1179. (PMID: 32031903)
Int J Mol Sci. 2021 Mar 05;22(5):. (PMID: 33807517)
Endocr Rev. 2021 Nov 16;42(6):691-719. (PMID: 33901271)
Am J Med Genet C Semin Med Genet. 2017 Dec;175(4):507-515. (PMID: 29152903)
Reproduction. 2018 Jul;156(1):F1-F10. (PMID: 29459401)
Contributed Indexing: Keywords: Female hypogonadism; Turner syndrome; estradiol; hormone p>replacement therapy; hypothalamic amenorrhea; premature ovarian insufficiency
Entry Date(s): Date Created: 20251203 Date Completed: 20251203 Latest Revision: 20251206
Update Code: 20251206
PubMed Central ID: PMC12676687
DOI: 10.20945/2359-4292-2025-0395
PMID: 41337668
Database: MEDLINE
Description
Abstract:Over the past year, three new key guidelines have been published in the area of female hypogonadism, one from the Society for Endocrinology covering the full spectrum of causes of female hypogonadism in adult life, which will form the core of this review; another solely covering premature ovarian insufficiency from a consortium comprising the International Menopause Society (IMS), the European Society of Human Reproduction & Embryology (ESHRE) and the American Society for Reproductive Medicine (ASRM) that updates the 2016 ESHRE guidance, and a third covering Turner syndrome across all stages of life from the International Turner Syndrome Consensus Group. In this review, we aim to synthesize the key elements from all of these documents, providing a timely update for clinicians managing affected women.
ISSN:2359-4292
DOI:10.20945/2359-4292-2025-0395